Heparanase Expression in Circulating Lymphocytes of Breast Cancer Patients Depends on the Presence of the Primary Tumor and/or Systemic Metastasis
Heparanase is an endo-β-glucuronidase that is capable of degrading heparan sulfate chains of proteoglycans, generating a variety of bioactive molecules such as growth factors and chemotactic and angiogenic agents. The expression of heparanase was investigated in the peripheral blood mononuclear cel...
Main Authors: | Thérése Rachell Theodoro, Leandro Luongo de Matos, Aleksandra Vanessa Lambiasi Sant Anna, Fernando Luiz Affonso Fonseca, Patrícia Semedo, Lourdes Conceição Martins, Helena Bonciani Nader, Auro Del Giglio, Maria Aparecida da Silva Pinhal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558607800078 |
Similar Items
-
Heparanase isoform expression and extracellular matrix remodeling in intervertebral disc degenerative disease
by: Luciano Miller Reis Rodrigues, et al.
Published: (2011-01-01) -
Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2
by: Miriam Gross-Cohen, et al.
Published: (2021-01-01) -
Crosstalk between tumor cells and lymphocytes modulates heparanase expression
by: Thérèse Rachell Theodoro, et al.
Published: (2019-03-01) -
Emerging Roles of Heparanase in Viral Pathogenesis
by: Neel Thakkar, et al.
Published: (2017-09-01) -
Heparanase and the hallmarks of cancer
by: Krishnath M. Jayatilleke, et al.
Published: (2020-11-01)